Top Section/Ad
Top Section/Ad
Most recent
Cell and gene therapy company plans US expansion
More articles/Ad
More articles/Ad
More articles
-
The region’s equity capital markets have reopened swiftly after the summer break -
The medical equipment company is funding its acquisition of Icelandic peer Kerecis with equity
-
The company’s share price dropped after H2 results
-
Nordic ECM issuance has been subdued in 2023, Dealogic data shows
-
The pre-revenue mining company is developing assets in the Balkans
-
Falling inflation and rallying equities have driven a strong recovery in US equity capital markets
